DOSEF

Doseology Sciences Inc.

USD

Set alert

Price alert · DOSEF

All alert types
0.10 USD 0.00 0.00%
As of Oct 29, 2026
0.1337 Day range 0.1337
0.0071 52-week range 1.00
YTD
-72.49%
1 year
-90.37%
Open
0.1337
Prev close
0.09629
Mkt cap
778.69K
Vol
5.00K
Avg vol
5
EPS
-0.10
P/E
0.00
More statistics
Low
0.1337
High
0.1337

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for DOSEF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-6.33 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -10.3×
FY 2020: -8.6×FY 2021: -21.9×FY 2022: -15.4×FY 2023: -10.6×FY 2024: -2.5×FY 2025: -10.3×
FY 2020 5y median -10.6× FY 2025
P/S 108×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 1857×FY 2023: 438×FY 2024: 8.8×FY 2025: 108×
FY 2020 5y median 108× FY 2025
P/B 2.4×
FY 2020: 3.3×FY 2021: 13.8×FY 2022: 9.9×FY 2023: 14.5×FY 2024: 0.9×FY 2025: 2.4×
FY 2020 5y median 9.9× FY 2025
P/FCF -9.9×
FY 2020: 0.0×FY 2021: -14.0×FY 2022: -17.3×FY 2023: -39.3×FY 2024: -3.7×FY 2025: -9.9×
FY 2020 5y median -14.0× FY 2025
EV/EBITDA -7.1×
FY 2020: -7.5×FY 2021: -23.3×FY 2022: -17.4×FY 2023: -9.8×FY 2024: 0.6×FY 2025: -7.1×
FY 2020 5y median -9.8× FY 2025
EV/Sales 74.6×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 1786×FY 2023: 409×FY 2024: -1.9×FY 2025: 74.6×
FY 2020 5y median 74.6× FY 2025
FCF Yield -10.1%
FY 2020: 0.0%FY 2021: -7.1%FY 2022: -5.8%FY 2023: -2.5%FY 2024: -27.1%FY 2025: -10.1%
FY 2020 5y median -7.1% FY 2025

Profitability

Gross Margin 60.4%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -924.6%FY 2023: 95.8%FY 2024: 73.2%FY 2025: 60.4%
FY 2020 5y median 60.4% FY 2025
Operating Margin -1108.2%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -11277.5%FY 2023: -1780.4%FY 2024: -383.3%FY 2025: -1108.2%
FY 2020 5y median -1108.2% FY 2025
Net Margin -1052.2%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -12084.5%FY 2023: -4134.7%FY 2024: -344.9%FY 2025: -1052.2%
FY 2020 5y median -1052.2% FY 2025
ROE -23.5%
FY 2020: -39.4%FY 2021: -63.1%FY 2022: -64.7%FY 2023: -137.1%FY 2024: -33.3%FY 2025: -23.5%
FY 2020 5y median -63.1% FY 2025
ROIC -24.3%
FY 2020: -39.4%FY 2021: -48.3%FY 2022: -49.2%FY 2023: -54.8%FY 2024: -37.0%FY 2025: -24.3%
FY 2020 5y median -48.3% FY 2025
ROA -30.0%
FY 2020: -36.4%FY 2021: -27.2%FY 2022: -50.1%FY 2023: -127.4%FY 2024: -30.8%FY 2025: -30.0%
FY 2020 5y median -30.8% FY 2025

Growth (YoY)

Revenue -68.3%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 168.5%FY 2024: 128.7%FY 2025: -68.3%
FY 2020 FY 2025
Operating Income 8.3%
FY 2020: 0.0%FY 2021: -270.5%FY 2022: -15.7%FY 2023: 57.6%FY 2024: 50.8%FY 2025: 8.3%
FY 2020 FY 2025
EPS (diluted) 10.7%
FY 2020: 0.0%FY 2021: 63.9%FY 2022: -24.9%FY 2023: 12.7%FY 2024: -84.8%FY 2025: 10.7%
FY 2020 FY 2025
Free Cash Flow -45.6%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 32.3%FY 2023: 72.0%FY 2024: 51.1%FY 2025: -45.6%
FY 2020 FY 2025

Financial Health

Current Ratio 21.6×
FY 2020: 13.2×FY 2021: 1.8×FY 2022: 13.6×FY 2023: 14.7×FY 2024: 13.4×FY 2025: 21.6×
FY 2020 5y median 13.6× FY 2025
Quick Ratio 21.3×
FY 2020: 13.2×FY 2021: 1.8×FY 2022: 13.5×FY 2023: 14.6×FY 2024: 12.9×FY 2025: 21.3×
FY 2020 5y median 13.5× FY 2025
Debt / Equity 0.0×
FY 2020: 0.0×FY 2021: 0.3×FY 2022: 0.2×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 3.2×
FY 2020: 0.8×FY 2021: 2.2×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 3.3×FY 2025: 3.2×
FY 2020 5y median 2.2× FY 2025
Interest Coverage 0.0×
FY 2020: 0.0×FY 2021: -22.9×FY 2022: -23.9×FY 2023: -21.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median -21.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-06-30